CHEK2 and breast carcinoma: High-risk individuals are those with a lifetime breast cancer risk exceeding 20%, including those with genetic mutations (BRCA1, BRCA2, CHEK2, and TP53), a strong family history of breast cancer, or a history of chest irradiation at a young age.